Manoogian, E.N.C., L.S. Chow, P.R. Taub, B. Laferrere, and S. Panda. 2022. Time-restricted Eating for the Prevention and Management of Metabolic Diseases. Endocrine Reviews 43 (2): 405–436. https://doi.org/10.1210/endrev/bnab027.
Fahed, G., L. Aoun, M. Bou. Zerdan, S. Allam, M. Bou Zerdan, Y. Bouferraa, and H.I. Assi. 2022. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International Journal of Molecular Sciences 23 (2). https://doi.org/10.3390/ijms23020786.
Colca, J.R., and P.E. Scherer. 2022. The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease. Molecular Metabolism 55: 101409. https://doi.org/10.1016/j.molmet.2021.101409.
CAS Article PubMed Google Scholar
Valanti, E.K., K. Dalakoura-Karagkouni, G. Siasos, D. Kardassis, A.G. Eliopoulos, and D. Sanoudou. 2021. Advances in biological therapies for dyslipidemias and atherosclerosis. Metabolism 116: 154461. https://doi.org/10.1016/j.metabol.2020.154461.
CAS Article PubMed Google Scholar
Atzeni, F., J. Rodriguez-Carrio, C.D. Popa, M.T. Nurmohamed, G. Szucs, and Z. Szekanecz. 2021. Cardiovascular effects of approved drugs for rheumatoid arthritis. Nature Reviews Rheumatology 17 (5): 270–290. https://doi.org/10.1038/s41584-021-00593-3.
Jebari-Benslaiman, S., U. Galicia-Garcia, A. Larrea-Sebal, J.R. Olaetxea, I. Alloza, K. Vandenbroeck, A. Benito-Vicente, and C. Martin. 2022. Pathophysiology of Atherosclerosis. International Journal of Molecular Sciences 23 (6). https://doi.org/10.3390/ijms23063346.
Roy, P., M. Orecchioni, and K. Ley. 2022. How the immune system shapes atherosclerosis: Roles of innate and adaptive immunity. Nature Reviews Immunology 22 (4): 251–265. https://doi.org/10.1038/s41577-021-00584-1.
CAS Article PubMed Google Scholar
Lin, L., M.X. Zhang, L. Zhang, D. Zhang, C. Li, and Y.L. Li. 2021. Autophagy, pyroptosis, and ferroptosis: New regulatory mechanisms for atherosclerosis. Frontiers in Cell and Developmental Biology 9: 809955. https://doi.org/10.3389/fcell.2021.809955.
Fan, J., and T. Watanabe. 2022. Atherosclerosis: Known and unknown. Pathology International 72 (3): 151–160. https://doi.org/10.1111/pin.13202.
Libby, P. 2021. The changing landscape of atherosclerosis. Nature 592 (7855): 524–533. https://doi.org/10.1038/s41586-021-03392-8.
CAS Article PubMed Google Scholar
Geovanini, G.R., and P. Libby. 2018. Atherosclerosis and inflammation: Overview and updates. Clinical Science (London, England) 132 (12): 1243–1252. https://doi.org/10.1042/CS20180306.
Wolf, D., and K. Ley. 2019. Immunity and Inflammation in Atherosclerosis. Circulation Research 124 (2): 315–327. https://doi.org/10.1161/CIRCRESAHA.118.313591.
CAS Article PubMed PubMed Central Google Scholar
Soehnlein, O., and P. Libby. 2021. Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nature Reviews. Drug Discovery 20 (8): 589–610. https://doi.org/10.1038/s41573-021-00198-1.
CAS Article PubMed PubMed Central Google Scholar
Doran, A.C. 2022. Inflammation resolution: Implications for atherosclerosis. Circulation Research 130 (1): 130–148. https://doi.org/10.1161/CIRCRESAHA.121.319822.
CAS Article PubMed Google Scholar
Kong, P., Z.Y. Cui, X.F. Huang, D.D. Zhang, R.J. Guo, and M. Han. 2022. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention. Signal Transduction and Targeted Therapy 7 (1): 131. https://doi.org/10.1038/s41392-022-00955-7.
CAS Article PubMed PubMed Central Google Scholar
Ley, K. 2021. Inflammation and Atherosclerosis. Cells 10 (5). https://doi.org/10.3390/cells10051197.
Yamada, S.M., and A. Pontillo. 2022. The genetics behind inflammasome regulation. Molecular Immunology 145: 27–42. https://doi.org/10.1016/j.molimm.2022.03.005.
CAS Article PubMed Google Scholar
Sharma, B.R., and T.D. Kanneganti. 2021. NLRP3 inflammasome in cancer and metabolic diseases. Nature Immunology 22 (5): 550–559. https://doi.org/10.1038/s41590-021-00886-5.
CAS Article PubMed PubMed Central Google Scholar
Pandey, A., C. Shen, S. Feng, and S.M. Man. 2021. Cell biology of inflammasome activation. Trends in Cell Biology 31 (11): 924–939. https://doi.org/10.1016/j.tcb.2021.06.010.
CAS Article PubMed Google Scholar
Kelley, N., D. Jeltema, Y. Duan, and Y. He. 2019. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. International Journal of Molecular Sciences 20 (13). https://doi.org/10.3390/ijms20133328.
Qiu, Y., Y. Huang, M. Chen, Y. Yang, X. Li, and W. Zhang. 2022. Mitochondrial DNA in NLRP3 inflammasome activation. International Immunopharmacology 108: 108719. https://doi.org/10.1016/j.intimp.2022.108719.
CAS Article PubMed Google Scholar
Kong, R., L. Sun, H. Li, and D. Wang. 2022. The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease. Autoimmunity 55 (1): 1–7. https://doi.org/10.1080/08916934.2021.1995860.
CAS Article PubMed Google Scholar
Paget, C., E. Doz-Deblauwe, N. Winter, and B. Briard. 2022. Specific NLRP3 inflammasome assembling and regulation in neutrophils: relevance in inflammatory and infectious diseases. Cells 11 (7). https://doi.org/10.3390/cells11071188.
Hochheiser, M., IV., G Hagelueken Pilsl, J. Moecking, M. Marleaux, R. Brinkschulte, E. Latz, C. Engel, and M. Geyer. 2022. Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3. Nature 604 (7904): 184–189. https://doi.org/10.1038/s41586-022-04467-w.
CAS Article PubMed Google Scholar
Thompson, R.C., A.H. Allam, G.P. Lombardi, L.S. Wann, M.L. Sutherland, J.D. Sutherland, M.A. Soliman, et al. 2013. Atherosclerosis across 4000 years of human history: The Horus study of four ancient populations. Lancet 381 (9873): 1211–1222. https://doi.org/10.1016/S0140-6736(13)60598-X.
Chu, C.S., S.H. Law, D. Lenzen, Y.H. Tan, S.F. Weng, E. Ito, J.C. Wu, C.H. Chen, H.C. Chan, and L.Y. Ke. 2020. Clinical significance of electronegative low-density lipoprotein cholesterol in atherothrombosis. Biomedicines 8 (8). https://doi.org/10.3390/biomedicines8080254.
Dutta, P., G. Courties, Y. Wei, F. Leuschner, R. Gorbatov, C.S. Robbins, Y. Iwamoto, et al. 2012. Myocardial infarction accelerates atherosclerosis. Nature 487 (7407): 325–329. https://doi.org/10.1038/nature11260.
CAS Article PubMed PubMed Central Google Scholar
Palasubramaniam, J., X. Wang, and K. Peter. 2019. Myocardial infarction-from atherosclerosis to thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 39 (8): e176–e185. https://doi.org/10.1161/ATVBAHA.119.312578.
CAS Article PubMed Google Scholar
Porsch, F., Z. Mallat, and C.J. Binder. 2021. Humoral immunity in atherosclerosis and myocardial infarction: From B cells to antibodies. Cardiovascular Research 117 (13): 2544–2562. https://doi.org/10.1093/cvr/cvab285.
CAS Article PubMed Google Scholar
Chandrasekar, B., and M. Alanbaei. 2020. Intracoronary imaging identifies plaque rupture underlying left main thrombosis in acute myocardial infarction without angiographically evident atherosclerosis. European Heart Journal 41 (46): 4448. https://doi.org/10.1093/eurheartj/ehaa849.
Tedeschi, D., A. Rizzi, S. Biscaglia, and C. Tumscitz. 2021. Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19. Catheterization and Cardiovascular Interventions 97 (2): 272–277. https://doi.org/10.1002/ccd.29179.
Loczi, L., J. Kappelmayer, T. Tarr, and Z. Bagoly. 2020. Antiphospholipid syndrome and the risk of myocardial infarction: Current evidence and uncertainties. Kardiologia Polska 78 (1): 6–14. https://doi.org/10.33963/KP.15090.
Shao, B.Z., B.Z. Han, Y.X. Zeng, D.F. Su, and C. Liu. 2016. The roles of macrophage autophagy in atherosclerosis. Acta Pharmacologica Sinica 37 (2): 150–156. https://doi.org/10.1038/aps.2015.87.
CAS Article PubMed PubMed Central Google Scholar
Emini Veseli, B., P. Perrotta, G.R.A. De Meyer, L. Roth, C. Van der Donckt, W. Martinet, and G.R.Y. De Meyer. 2017. Animal models of atherosclerosis. European Journal of Pharmacology 816: 3–13. https://doi.org/10.1016/j.ejphar.2017.05.010.
CAS Article PubMed Google Scholar
Miao, J., X. Zang, X. Cui, and J. Zhang. 2020. Autophagy, Hyperlipidemia, and Atherosclerosis. Advances in Experimental Medicine and Biology 1207: 237–264. https://doi.org/10.1007/978-981-15-4272-5_18.
CAS Article PubMed Google Scholar
Fredman, G. 2020. Devouring atherosclerotic plaques. Nature Nanotechnology 15 (2): 84–85. https://doi.org/10.1038/s41565-019-0599-3.
CAS Article PubMed Google Scholar
Jinnouchi, H., Y. Sato, A. Sakamoto, A. Cornelissen, M. Mori, R. Kawakami, N.V. Gadhoke, F.D. Kolodgie, R. Virmani, and A.V. Finn. 2020. Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability. Atherosclerosis 306: 85–95. https://doi.org/10.1016/j.atherosclerosis.2020.05.017.
CAS Article PubMed Google Scholar
Munjal, A., and R. Khandia. 2020. Atherosclerosis: Orchestrating cells and biomolecules involved in its activation and inhibition. Advances in Protein Chemistry and Structural Biology 120: 85–122. https://doi.org/10.1016/bs.apcsb.2019.11.002.
CAS Article PubMed Google Scholar
Linton, M.R.F., P.G. Yancey, S.S. Davies, W.G. Jerome, E.F. Linton, W.L. Song, A.C. Doran, and K.C. Vickers. 2000. The Role of Lipids and Lipoproteins in Atherosclerosis. In Endotext, eds. K. R. Feingold, and B. Anawalt, and A. Boyce, and G. Chrousos, and W. W. de Herder, and K. Dhatariya, and K. Dungan et al. South Dartmouth (MA).
Li, J., Q. Meng, Y. Fu, X. Yu, T. Ji, Y. Chao, Q. Chen, Y. Li, and H. Bian. 2021. Novel insights: Dynamic foam cells derived from the macrophage in atherosclerosis. Journal of Cellular Physiology 236 (9): 6154–6167. https://doi.org/10.1002/jcp.30300.
CAS Article PubMed Google Scholar
Tabas, I., and K.E. Bornfeldt. 2016. Macrophage phenotype and function in different stages of atherosclerosis. Circulation Research 118 (4): 653–667. https://doi.org/10.1161/CIRCRESAHA.115.306256.
CAS Article PubMed PubMed Central Google Scholar
Maguire,
留言 (0)